Lapix Therapeutics: Funding, Investors & Team (Oct 2026)
Lapix Therapeutics is a company that focuses on immune system modulation, aiming to develop treatments that can slow the progression of disease, maintain a strong immune response, and improve the safety profiles of other medications.
Lapix Therapeutics has raised $8.1M across 2 funding rounds on record, the most recent an undisclosed round of $2.2M announced in Aug 2024.
That round is below the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Lapix Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2024.
Lapix Therapeutics Funding Rounds
Lapix Therapeutics raised $5.9M in an undisclosed round announced in Apr 2023.
1.3 years later, an undisclosed round of $2.2M was announced in Aug 2024.
Lapix Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Lapix Therapeutics Funding Compared to Other Health Care Startups
Lapix Therapeutics' latest round of $2.2M is below the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lapix Therapeutics in Health Care and Boston
Companies Similar to Lapix Therapeutics
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Lapix Therapeutics Funding FAQs
What does Lapix Therapeutics do?
Lapix Therapeutics is a company that focuses on immune system modulation, aiming to develop treatments that can slow the progression of disease, maintain a strong immune response, and improve the safety profiles of other medications.
How much funding has Lapix Therapeutics raised?
Lapix Therapeutics has raised $8.1M across 2 rounds on record. The most recent is an undisclosed round of $2.2M announced in Aug 2024.
When did Lapix Therapeutics last raise funding?
Lapix Therapeutics' most recent funding round on record is an undisclosed round of $2.2M, announced in Aug 2024.
Who founded Lapix Therapeutics?
FundedIQ lists Anas Fathallah (Founder) at Lapix Therapeutics.
Where is Lapix Therapeutics headquartered?
Lapix Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Lapix Therapeutics have?
Lapix Therapeutics is in the 11-50 employee band.
How does Lapix Therapeutics' funding compare to other Health Care startups?
Lapix Therapeutics' latest round of $2.2M is below the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Lapix Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lapix Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.